Sun. Oct 1st, 2023

AI Medical Service Raises US$70M in Series C Financing

JAPANPublished on April 26, 2022

AI Medical Service, a Tokyo, Japan-based med-tech company using deep learning technology to develop endoscopic AI, raised US$70M in Series C funding.

The round was led by SoftBank Vision Fund 2 (SVF2) with participation from Globis Capital Partners, World Innovation Lab (WiL), and Incubate Fund.

The company intends to use the funds for
1. Acceleration of global business development
– Driving joint research and product development with medical institutions in the U.S., Asia-Pacific region, etc.
– Acquiring the talent necessary to expand global business

2. Developing a proprietary cloud platform to eliminate GI cancer around the world
– Creating an in-house cloud platform that connects endoscopy rooms around the world to AIM’s endoscopic AI.

AI Medical Service (AIM) is a medtech company leading player in the field of cloud-based endoscopic AI, engaging in joint research with more than 100 medical institutions with the aim of bringing endoscopic AI to real-world clinical setting as soon as possible to reduce the number of missed cancer diagnoses and save lives.




Leave a Reply

Your email address will not be published. Required fields are marked *